Entecavir plus adefovir or entecavir plus tenofovir for patients with chronic hepatitis B resistant to neucleot(s)ide analogues

被引：0
|
作者：
Park, Jung Gil [1 ]
Kweon, Young Oh [2 ]
Tak, Won Young [2 ]
Jang, Se Young [2 ]
Lee, Su Hyun [2 ]
Park, Soo Young [2 ]
机构：
[1] CHA Univ Gumi CHA Med Ctr, Gumi, South Korea
[2] Kyungpook Natl Univ, Sch Med, Taegu, South Korea
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1903
引用
收藏
页码：1116A / 1116A
页数：1
相关论文
共 50 条
  • [31] Letter: treatment of HBeAg plus chronic hepatitis B - is tenofovir truly superior to entecavir? Author's reply
    Gao, L.
    Trinh, H. N.
    Li, J.
    Nguyen, M. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (11) : 1339 - 1340
  • [32] Chronic Hepatitis B: Tenofovir and Entecavir compared
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (09):
  • [33] THE ENTEBE STUDY: SAFETY AND EFFICACY OF ENTECAVIR PLUS TENOFOVIR IN ADULTS WITH CHRONIC HEPATITIS B AND PREVIOUS NUCLEOS(T)IDE TREATMENT FAILURE
    Simon, K.
    Diculescu, M.
    Janssen, H. L. A.
    Zoulim, F.
    Petersen, J.
    Marcellin, P.
    Klauck, I.
    Pans, M.
    Bendahmane, S.
    Jablkowski, M.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S215 - S215
  • [34] Comparable efficacy with entecavir monotherapy and tenofovir-entecavir combination in chronic hepatitis B patients
    Baqai, Sumbella
    Proudfoot, James
    Xu, Ronghui
    Kane, Steve
    Clark, Margaret
    Gish, Robert
    BMJ OPEN GASTROENTEROLOGY, 2015, 2 (01):
  • [35] Efficacy of 2 years of entecavir plus adefovir therapy in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analog treatment
    Wang, Xiaohong
    Zhang, Changjiang
    Zhu, Yan
    Xiong, Yulin
    Wang, Yuming
    ANTIVIRAL RESEARCH, 2014, 103 : 71 - 77
  • [36] Comparison of entecavir and adefovir for the treatment of chronic hepatitis B
    Zhao, Si-Hai
    Liu, En-Qi
    Cheng, Da-Xin
    Li, Ya-Feng
    Wang, Yan-Li
    Chen, Yu-Long
    Sun, Wen-Tao
    Yan, Xi-Cai
    Dang, Shuang-Suo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (04): : 366 - 372
  • [37] Efficacy of Entecavir in Patients with Chronic Hepatitis B Resistant to Both Lamivudine and Adefovir or to Lamivudine Alone
    Shim, Ju Hyun
    Suh, Dong Jin
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    HEPATOLOGY, 2009, 50 (04) : 1064 - 1071
  • [38] Entecavir plus adefovir combination therapy versus lamivudine add-on adefovir for lamivudine-resistant chronic hepatitis B: A meta-analysis
    Zeng, Teng
    Xu, Hua
    Liu, Jun-Ying
    Lei, Yu
    Zhong, Shan
    Zhou, Zhi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (09): : 959 - 967
  • [39] Tenofovir Disoproxil Fumarate Alone or in Combination With Entecavir in Patients With Entecavir-Resistant Chronic Hepatitis B: Multicenter Randomized Trial
    Lim, Young-Suk
    Byun, Kwan Soo
    Gwak, Geum-Youn
    Yoo, Byung Chul
    Kwon, So Young
    Kim, Yoon Jun
    An, Jihyun
    Lee, Han Chu
    Lee, Yung Sang
    HEPATOLOGY, 2014, 60 : 315A - 315A
  • [40] Comparison of re-treatment outcomes of lamivudine plus adefovir or entecavir in chronic hepatitis B patients with viral relapse after cessation of adefovir
    Wang, J. C.
    He, L. L.
    Chen, Q.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (09) : 1162 - 1166
12345